White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

Not recruiting

2 1
Investigated Diseases:
- Acute kidney injury
- Sepsis
Investigated Drugs:
- Tin816
+2
Study on Sentinel Node Detection in Early-Stage Cervical Cancer Using Indocyanine Green Compared to 99mTc and Blue Dye

Not recruiting

3 1 1 1
Investigated Drugs:
- Indocyanine Green
Study on Selumetinib for Children Aged 1 to 6 with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Not recruiting

1 1 1 1
Investigated Diseases:
- Neurofibromatosis
Investigated Drugs:
- Selumetinib
Study on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy

Not recruiting

2 1
Investigated Diseases:
- Chronic hepatitis B
- Hepatitis B
Investigated Drugs:
+2
Study on Pain Relief After Hip Replacement Surgery Using Morphine, Ropivacaine, and Bupivacaine for Patients Undergoing Spinal Anesthesia

Not recruiting

3 1 1
Investigated Diseases:
- Hip arthroplasty
Investigated Drugs:
Study on the Effectiveness and Safety of REL-1017 for Patients with Major Depression Who Have Not Responded to Current Treatment

Not recruiting

3 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Dextromethadone Hydrochloride
Study on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis

Not recruiting

3 1 1
Investigated Drugs:
+3
Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

Not recruiting

2 1 1
Investigated Drugs:
- Vericiguat
Study on the Long-term Safety of Cenobamate for Patients with Primary Generalized Tonic-Clonic Seizures

Not recruiting

3 1
Investigated Drugs:
- Cenobamate
Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Not recruiting

2 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Ianalumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies